Press Pulse

Recent news articles covering relevant topics related to prescription drug abuse and efforts to reduce it

10 Mar 2016

This Canadian Drug Policy Is Killing Americans Too

The first bilateral meeting of the newly installed Canadian prime minister and the American president is slated for this week, a summit that promises to include more pomp than policy--and that's a unique travesty as a long-simmer dispute in prescription drug policy between the two nations continues to enable crippling addiction across the continent.

More ...

10 Mar 2016

Could abuse resistant pain-killers help in fight against NH opioid crisis?

CONCORD - With the Granite State facing an opioid epidemic, here's something to consider. Many addicts became addicted after being prescribed a drug for a legitimate health problem. What if those prescriptions drugs weren't addictive to start?

A new national survey reports 65% of U.S. adults believe the Food & Drug Administration should require pharmaceutical companies to include an abuse deterrent formulation (ADF) in all of their most abused drugs, both name-brand and generic.

More ...

02 Mar 2016

FDA's Abuse-Deterrent Commissioner

Yesterday the FDA Science Board discussed the agency’s approach to opioids.

FDA presenters included agency point-man Doug Throckmorton (Deputy Director for Regulatory Programs, CDER), Janet Woodcock (Director, CDER), Sharon Hertz (Division Director, Division of Anesthesiology, Analgesia and Addiction Products), Gerald Dal Pan (Director, Office of Surveillance and Epidemiology) – and newly confirmed FDA Commissioner Rob Califf.

More ...

23 Feb 2016

Grünenthal formulates deal with Patheon for anti-abuse technology

Grünenthal has selected Patheon as its preferred development partner for its anti-abuse formulation platform INTAC, based on Hot Melt Extrusion (HME) technology...

More ...

19 Feb 2016

Efforts Expand on Abuse-Deterrent Hydrocodone

PALM SPRINGS, Calif. – Abuse-deterrent formulations of hydrocodone appear to work as promised, studies presented here indicated, although whether they can thwart real-life abusers remains to be seen.

In one, recreational opioid users allowed to try both a conventional immediate-release product and an abuse-deterrent form -- made so that it can't be crushed into a snortable powder -- in a cross-over format told the investigators that they preferred the immediate-release formulation.

More ...

16 Feb 2016

Bills, FDA can help deter abuse of prescription opioids

In response to the opioid-abuse epidemic, leaders of the U.S. Food and Drug Administration have called for a far-reaching action plan to reassess the agency's approach to opioid medications. The FDA has been diligently assessing and approving pain medications designed to minimize abuse. Many manufacturers offer various abuse-deterrent formulations and products that contain the active opioid, but cannot be crushed, chewed, snorted or injected.

More ...

15 Feb 2016

Bill to require abuse deterrents along with opioid prescriptions moves to House

CHARLESTON, W.Va. — A bill that would require insurance companies to provide abuse deterrents alongside prescriptions for opioid painkillers passed the House of Delegates overwhelmingly on Monday. The 89-9 vote sent the bill to the Senate. One of the bill’s sponsors, Del. Chris Stansbury (R-Kanawha), said on the House floor Monday that opioids aren’t going away, so the next best move is making them safer.

More ...

08 Feb 2016

Fact Sheet FDA Opioids Action Plan

The FDA is deeply concerned about the growing epidemic of opioid abuse, dependence and overdose in the United States. In response to this crisis, the agency has developed a comprehensive action plan to take concrete steps toward reducing the impact of opioid abuse on American families and communities.

More ...

13 Jan 2016

Bill encouraging insurance companies to cover abuse-deterrent opioids passes first Florida House subcommittee

13 January 2016 TALLAHASSEE -- A Florida lawmaker is trying to make it easier for those who need painkillers to have access to opioids that are less likely to cause addiction, and for those looking for medication-assisted treatment for their addictions.

The bill, sponsored by Rep. Jeanette M. Nuñez, R-Miami, was approved Wednesday by the House Health Innovation Subcommittee, 12-1.

More ...

28 Dec 2015

INTAC Press Pulse: NJ lawmaker wants health insurers to cover abuse-deterrent opioids

28 December 2015, New Jersey - New Jersey is in the throes of an opioid abuse epidemic said state Sen. Joe Vitale (D-Woodbridge). There are abuse-deterrent opioids on the market, but health insurers in the Garden State are not required to cover them. Legislation (S-3036) sponsored by Vitale would change that. drugs

More ...

previous [10] next [10]